NPA
NVO

Nichols & Pratt Advisers’s Novo Nordisk NVO Stock Holding History

Nichols & Pratt Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Sell
480,319
-7,306
-1% -$346K 1.14% 26
2025
Q4 		$24.8M Sell
487,625
-13,366
-3% -$683K 1.55% 23
2025
Q3 		$27.8M Buy
500,991
+8,935
+2% +$523K 1.76% 22
2025
Q2 		$34M Buy
492,056
+10,742
+2% +$731K 2.28% 16
2025
Q1 		$33.4M Buy
481,314
+3,435
+0.7% +$284K 2.28% 17
2024
Q4 		$41.1M Sell
477,879
-10,331
-2% -$1.12M 2.74% 15
2024
Q3 		$58.1M Sell
488,210
-8,005
-2% -$1.07M 3.75% 10
2024
Q2 		$70.8M Sell
496,215
-305
-0.1% -$40.4K 4.79% 6
2024
Q1 		$63.7M Sell
496,520
-6,080
-1% -$724K 4.29% 8
2023
Q4 		$52M Sell
502,600
-6,460
-1% -$639K 3.7% 10
2023
Q3 		$46.2M Sell
509,060
-2,780
-0.5% -$245K 3.5% 10
2023
Q2 		$41.4M Sell
511,840
-4,122
-0.8% -$337K 3.01% 11
2023
Q1 		$41M Sell
515,962
-7,612
-1% -$540K 3.15% 10
2022
Q4 		$35.5M Sell
523,574
-880
-0.2% -$51.6K 2.85% 10
2022
Q3 		$26.1M Sell
524,454
-1,970
-0.4% -$106K 2.32% 15
2022
Q2 		$29.3M Sell
526,424
-920
-0.2% -$51.1K 2.4% 15
2022
Q1 		$29.3M Buy
527,344
+100
+0% +$5.13K 2.12% 16
2021
Q4 		$29.5M Sell
527,244
-550
-0.1% -$29.8K 2.04% 17
2021
Q3 		$25.3M Sell
527,794
-90
-0% -$4.35K 1.92% 17
2021
Q2 		$22.1M Buy
527,884
+330
+0.1% +$12.8K 1.67% 22
2021
Q1 		$17.8M Sell
527,554
-1,070
-0.2% -$38.1K 1.39% 27
2020
Q4 		$18.5M Sell
528,624
-1,602
-0.3% -$55.4K 1.47% 23
2020
Q3 		$18.4M Buy
530,226
+1,516
+0.3% +$50.5K 1.59% 22
2020
Q2 		$17.3M Sell
528,710
-2,770
-0.5% -$88.4K 1.55% 23
2020
Q1 		$16M Buy
531,480
+3,628
+0.7% +$108K 1.6% 23
2019
Q4 		$15.3M Sell
527,852
-4,130
-0.8% -$114K 1.26% 27
2019
Q3 		$13.7M Buy
531,982
+31,390
+6% +$794K 1.12% 33
2019
Q2 		$12.8M Buy
500,592
+8,006
+2% +$198K 1.05% 31
2019
Q1 		$12.9M Buy
492,586
+12,526
+3% +$308K 1.08% 31
2018
Q4 		$11.1M Buy
480,060
+19,408
+4% +$431K 1.04% 31
2018
Q3 		$10.8M Buy
460,652
+12,642
+3% +$309K 0.9% 39
2018
Q2 		$10.3M Buy
448,010
+15,200
+4% +$361K 0.92% 39
2018
Q1 		$10.6M Hold
432,810
– – 0.97% 36
2017
Q4 		$11.6M Buy
432,810
+900
+0.2% +$22.9K 1.01% 36
2017
Q3 		$10.4M Sell
431,910
-2,000
-0.5% -$45.2K 0.93% 37
2017
Q2 		$9.3M Buy
433,910
+7,390
+2% +$149K 0.85% 38
2017
Q1 		$7.31M Buy
426,520
+144,872
+51% +$2.52M 0.67% 41
2016
Q4 		$5.05M Sell
281,648
-3,422
-1% -$62K 0.48% 43
2016
Q3 		$5.93M Buy
285,070
+4,080
+1% +$101K 0.54% 41
2016
Q2 		$7.57M Sell
280,990
-980
-0.3% -$26.9K 0.69% 42
2016
Q1 		$7.65M Buy
281,970
+18,466
+7% +$495K 0.71% 41
2015
Q4 		$7.65M Buy
263,504
+2,770
+1% +$76.7K 0.73% 39
2015
Q3 		$7.08M Buy
260,734
+29,650
+13% +$839K 0.71% 41
2015
Q2 		$6.34M Buy
231,084
+9,330
+4% +$262K 0.59% 44
2015
Q1 		$5.92M Buy
221,754
+5,874
+3% +$135K 0.54% 42
2014
Q4 		$4.57M Buy
215,880
+800
+0.4% +$17.9K 0.4% 47
2014
Q3 		$5.12M Buy
215,080
+27,810
+15% +$640K 0.46% 46
2014
Q2 		$4.33M Buy
187,270
+33,000
+21% +$729K 0.37% 47
2014
Q1 		$3.51M Buy
+154,270
New +$3.29M 0.32% 51

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Nichols & Pratt Advisers's NVO Position: Q1 2026 in Review

Nichols & Pratt Advisers reduced its Novo Nordisk (NVO) stake by 1.5% in Q1 2026, selling an estimated $346K and leaving 480,319 shares worth $17.7M. The position accounts for 1.14% of the portfolio, ranked #26.

Nichols & Pratt Advisers first reported a position in NVO in Q1 2014 and has held it in 49 quarters since. The position peaked at $70.8M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Nichols & Pratt Advisers held 480,319 shares of Novo Nordisk worth $17.7M as of Q1 2026.
  • Nichols & Pratt Advisers sold 7,306 Novo Nordisk shares in Q1 2026, an estimated $346K.
  • Novo Nordisk made up 1.14% of Nichols & Pratt Advisers's portfolio in Q1 2026, its #26 holding.
  • Nichols & Pratt Advisers first reported a position in Novo Nordisk in Q1 2014 and has held it in 49 quarters since.
  • Nichols & Pratt Advisers's Novo Nordisk position peaked at $70.8M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2026, filed 29 Apr 2026.